Liver cancer is the sixth leading cause of cancer death in the U.S. The most common type of liver cancer in adults is hepatocellular carcinoma (HCC),...

Discover how mini-proteins deliver targeted radiation to Nectin-4 expressing tumor cells, sparing healthy tissues and offering new hope for cancer...

Researchers at Winship Cancer Institute of Emory University have identified a novel type of immune cell, called the stem-like CD4 T cell, that plays a...

Contrary to concerns, GLP-1RA medications don't appear to elevate AKI risk in patients undergoing cancer treatment.

It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit from immunotherapy,...

Glucagon-like peptide-1-receptor agonists (GLP-1RA) are medications that are increasingly prescribed for patients with type 2 diabetes and congestive...

Glucagon-like peptide-1-receptor agonists (GLP-1RA) are medications that are increasingly prescribed for patients with type 2 diabetes and congestive...

In patients with medlinkchronic kidney disease/medlink, irreversible disease progression is triggered by the loss of podocytes, essential components...

MONDAY, Oct. 28, 2024 -- Most thyroid cancers are slow-moving and, if caught early, curable. But some patients can present with what's known as an...

Early detection of hepatocellular carcinoma (HCC) is crucial for improving survival in patients with chronic hepatitis.